HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A M Feldman Selected Research

Therapeutics

10/2007Polymorphisms in adenosine receptor genes are associated with infarct size in patients with ischemic cardiomyopathy.
9/2001Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model.
8/2001Effects of vesnarinone on peripheral circulating levels of cytokines and cytokine receptors in patients with heart failure: a report from the Vesnarinone Trial.
6/2001The International EECP Patient Registry (IEPR): design, methods, baseline characteristics, and acute results.
5/2001Effects of soluble TNF receptor treatment on lipopolysaccharide-induced myocardial cytokine expression.
3/2001Pharmacogenetic interactions between beta-blocker therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
2/2001Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.
9/2000Heart failure management using implantable devices for ventricular resynchronization: Comparison of Medical Therapy, Pacing, and Defibrillation in Chronic Heart Failure (COMPANION) trial. COMPANION Steering Committee and COMPANION Clinical Investigators.
7/2000Trastuzumab in the treatment of metastatic breast cancer : anticancer therapy versus cardiotoxicity.
6/2000From clinical trials to clinical practice: what we know and do not know about beta-blockers and the heart.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


A M Feldman Research Topics

Disease

24Heart Failure
04/2014 - 03/2000
6Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
11/2001 - 05/2000
4Cardiomyopathies (Cardiomyopathy)
10/2007 - 05/2000
4Neoplasms (Cancer)
06/2007 - 03/2000
3Heart Diseases (Heart Disease)
06/2001 - 03/2000
2Myocarditis (Carditis)
12/2007 - 05/2001
2Cardiomegaly (Heart Hypertrophy)
09/2001 - 07/2001
2Inflammation (Inflammations)
07/2001 - 05/2000
2Cardiotoxicity
06/2001 - 07/2000
2Fibrosis (Cirrhosis)
01/2001 - 05/2000
2Coronary Artery Disease (Coronary Atherosclerosis)
01/2001 - 08/2000
2Hypertrophy
11/2000 - 05/2000
1Ischemia
10/2007
1Infarction (Infarctions)
10/2007
1Disease Progression
08/2001
1Angina Pectoris
06/2001
1Tetany (Spasmophilia)
06/2001
1Endotoxemia
05/2001
1Septic Shock (Toxic Shock Syndrome)
05/2001
1Myocardial Ischemia (Ischemic Heart Diseases)
04/2001
1Cardiovascular Diseases (Cardiovascular Disease)
01/2001
1Arthritis (Polyarthritis)
01/2001
1Breast Neoplasms (Breast Cancer)
07/2000
1Ventricular Remodeling
05/2000
1Rheumatoid Arthritis
03/2000
1Crohn Disease (Crohn's Disease)
03/2000
1Cachexia
03/2000
1Necrosis
03/2000

Drug/Important Bio-Agent (IBA)

13Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
12/2007 - 03/2000
8CytokinesIBA
08/2001 - 03/2000
4Tumor Necrosis Factor Receptors (Tumor Necrosis Factor Receptor)IBA
12/2007 - 05/2000
4Matrix Metalloproteinases (MMPs)IBA
03/2001 - 05/2000
3vesnarinoneIBA
08/2001 - 08/2000
3Interleukin-6 (Interleukin 6)IBA
05/2001 - 09/2000
2Trastuzumab (Herceptin)FDA Link
06/2007 - 07/2000
2Adrenergic Agents (Adrenergic Drugs)IBA
09/2001 - 06/2000
2Cytokine Receptors (Cytokine Receptor)IBA
08/2001 - 04/2001
2Etanercept (Enbrel)FDA Link
02/2001 - 02/2001
2CollagenIBA
01/2001 - 11/2000
1Antidiuretic Hormone Receptor AntagonistsIBA
04/2014
1Proteins (Proteins, Gene)FDA Link
12/2007
1Immunoglobulin G (IgG)IBA
12/2007
1Purinergic P1 Receptors (Adenosine Receptor)IBA
10/2007
1Adenosine (Adenocard)FDA LinkGeneric
10/2007
1DNA (Deoxyribonucleic Acid)IBA
10/2007
1Cyclooxygenase InhibitorsIBA
06/2007
1Pharmaceutical PreparationsIBA
06/2007
1Purinergic P1 Receptor AgonistsIBA
06/2007
1Mitochondrial DNA (mtDNA)IBA
11/2001
1CatecholaminesIBA
09/2001
1Nitric Oxide (Nitrogen Monoxide)FDA Link
06/2001
1Superoxides (Superoxide)IBA
06/2001
1Peroxynitrous Acid (Peroxynitrite)IBA
06/2001
1Intravenous Immunoglobulins (IVIG)FDA Link
05/2001
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
03/2001
1ReninIBA
03/2001
1AngiotensinsIBA
03/2001
1omega-Chloroacetophenone (Mace)IBA
01/2001
1Matrix Metalloproteinase InhibitorsIBA
01/2001
1Glyceraldehyde-3-Phosphate Dehydrogenases (GAPD)IBA
09/2000
1InterleukinsIBA
09/2000
1Estrogens (Estrogen)FDA Link
08/2000
1AnthracyclinesIBA
07/2000
1Monoclonal AntibodiesIBA
07/2000
1Basigin (Extracellular Matrix Metalloproteinase Inducer (EMMPRIN))IBA
05/2000
1EndotoxinsIBA
03/2000

Therapy/Procedure

13Therapeutics
10/2007 - 03/2000
2Heart-Assist Devices
09/2000 - 05/2000
1Lung Transplantation
12/2001
1Heart Transplantation (Grafting, Heart)
09/2001
1Counterpulsation (External Counterpulsation)
01/2001